The 40 references in paper O Vasil'eva S., L. Kuz'mina P., N. Kravchenko Yu., О. Васильева С., Л. Кузьмина П., Н. Кравченко Ю. (2017) “Роль молекулярно-генетических исследований в диагностике и профилактике развития профессиональных заболеваний органов дыхания // A role of molecular analysis for diagnosis and prevention of occupational lung diseases” / spz:neicon:pulmonology:y:2017:i:2:p:198-205

1
Bang K.M. Chronic obstructive pulmonary diseases in nonsmokers by occupation and exposure: a brief review. Curr. Opin. Pulm. Med. 2015, 21 (2): 149–154. DOI: 10.1097/ MCP.0000000000000135.
(check this in PDF content)
2
Baur X., Sigsgaard T., Aasen T.B. et al. Guidelines for the management of work-related asthma.Eur. Respir. J. 2012;
(check this in PDF content)
3
3): 529–545. DOI: 10.1183/09031936.00096111. 3. Nicholson P.J., Cullinan P., Burge P.S., Boyle C. Occupational asthma: Prevention, identification and management: Systematic review and recommendations. London: British Occupational Health Research Foundation; 2010. Available at: http://www.bohrf.org.uk/downloads/OccupationalAsthma EvidenceReview-Mar2010.pdf
(check this in PDF content)
4
Henneberger P.K., Redlich C.A., Callahan D.B. et al. An official American Thoracic Society statement: work-exacerbated asthma.Am. J. Respir. Crit. Care Med.2011; 184 (3): 368–378. DOI: 10.1164/rccm.812011ST.
(check this in PDF content)
5
Tarlo S., Cullinan P., Nemery B., eds. Occcupational and Environmental Lung Diseases: Diseases from Work, Home, Outdoor and Other Exposures. Oxford: Wiley-Blackwell; 2010.
(check this in PDF content)
6
Lopez A.D., Shibuya K., Rao C. et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 2006; 27 (2): 397–412. DOI: 10.1183/ 09031936.06.00025805.
(check this in PDF content)
7
Salvi S. Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease. Clin. Chest Med. 2014; 35 (1): 17–27. DOI: 10.1016/j.ccm.2013.09.011.
(check this in PDF content)
8
American Lung Association. Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet. 2014. Available at: http:// www.lung.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html
(check this in PDF content)
9
Fishwick D., Sen D., Barber C. et al. Occupational chronic obstructive pulmonary disease: a standard of care.Occup. Med.(Lond.). 2015; 65 (4): 270–282. DOI: 10.1093/occmed/ kqv019.
(check this in PDF content)
10
Bang K.M., Syamlal G., Mazurek J.M., Wassell J.T. Chronic obstructive pulmonary disease prevalence among nonsmokers by occupation in the United States.J. Occup. Environ. Med. 2013; 55 (9): 1021–1026. DOI: 10.1097/ JOM.0b013e31829baa97.
(check this in PDF content)
11
Hnizdo E., Sullivan P.A., Bang K.M., Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 2002; 156 (8): 738–746.
(check this in PDF content)
12
Evans J., Chen Y., Camp P.G. et al. Estimating the prevalence of COPD in Canada: Reported diagnosis versus measured airflow obstruction. Health Rep. 2014; 25 (3): 3–11.
(check this in PDF content)
13
Lamprecht B., McBurnie M.A., Vollmer W.M. et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011; 139 (4): 752– 763. DOI: 10.1378/chest.10-1253.
(check this in PDF content)
14
Christiani D.S., Mehta A.J., Yu C.L. Genetic susceptibility to occupational exposures. Occup. Environ. Med.2008; 65 (6): 430–436. DOI: 10.1136/oem.2007.033977.
(check this in PDF content)
15
Shulte P.A., Whittaker C., Curran C.P. Consideration for Using Genetics and Epigenetic Information in Occupational Health Risk Assessment and Standard Settings. J. Occup. Inviron. Hyg. 2015; 12 (Suppl. 1): S69–S68. DOI: 10.1080/15459624.2015.1060323.
(check this in PDF content)
16
Brandt-Rauf P.W., Brandt-Rauf S.I. Genetic testing in the workplace: ethical, legal, and social implications. Ann. Rev. Public Health. 2004; 25: 139–153. DOI: 10.1146/annurev. publhealth.25.101802.123012.
(check this in PDF content)
17
Chiu W.A., Euling S.Y., Scott C.S., Subramaniam R.P. Approaches to advancing quantitative human health risk assessment of environmental chemicals in the post-genomic era. Toxicol. Appl. Pharmacol. 2013; 271 (3): 309–323. DOI: 10.1016/j.taap.2010.03.019.
(check this in PDF content)
18
Mapp C.E., Boscetto P., Maestrell P., Fabri G.M. Occupational asthma. Am. J. Respir. Crit. Care Med. 2005; 172 (3): 280–305. DOI: 10.1164/rccm.200311-1575SO.
(check this in PDF content)
19
Chung C.C., Magalhaes W.C.S., Gonzalez-Bosquet J., Chanock S.J. Genome-wide association studies in cancer–current and future directions. Carcinogenesis. 2010; 31 (1): 111–120. DOI: 10.1093/carcin/bgp273.
(check this in PDF content)
20
Cullen A.C., Corrales M.A., Kramer C.B., Faustman E.M. The application of genetic information for regulatory standard setting under the clean air act: a decision-analytic approach. Risk. Anal. 2008; 28 (4): 877–890. DOI: 10.1111/ j.1539-6924.2008.01084.x.
(check this in PDF content)
21
Dolinoy D.C., Weidman J.R., Jirtle R.L. Epigenetic gene regulation: Linking early development to adult disease. Reproduct. Toxicol.2007; 23: 297–298. DOI: 10.1016/ j.reprotox.2006.08.012.
(check this in PDF content)
22
Garte S. Individual susceptibility and gene-environment interaction. In: Wild C., Vineis P., Garte S., eds. Molecular Epidemiology of Chronic Disease. West Sussex: John Wiley and Sons, Ltd; 2008: 55–69.
(check this in PDF content)
23
Grodsky J.A. Genetics and environmental law: redefining public health. Calif. Law Rev. 2005; 92 (1): 171–270. DOI: 10.15779/Z38QQ74.
(check this in PDF content)
24
Sundberg M. Genetic variability in susceptibility and response to toxicants. Toxicol. Lett.2005; 120 (1–3): 259–268.
(check this in PDF content)
25
Николаев В.М., Иванова Ф.Г., Чирикова Н.К. и др. Изучение полиморфизма генов GSTT1 и GSTM1 у больных раком легкого в республике Саха. Фундаментальные исследования. 2014; 11: 1949–1953. Васильева О.С. и др. Роль молекулярно-генетических исследований в диагностике заболеваний органов дыхания
(check this in PDF content)
26
Rahman I., MacNee W. Oxidative stress and regulation of glutathione in lung inflammation.Eur. Respir. J.2000, 16 (3): 534–554.
(check this in PDF content)
27
Murcray C.E., Lewinger J.P., Gauderman W.J. Gene-environment interaction in genome-wide association studies. Am. J. Epidemiol.2009; 169 (2): 219–226. DOI: 10.1093/ aje/kwn353.
(check this in PDF content)
28
Department of Health and Human Services Centers for Disease Control and Prevention National Institute for Occupational Safety and Health. Genetics in the Workplace: Implications for Occupational Safety and Health. Genetics Working Group. 2010; 2010-101. Available at: https:// www.cdc.gov/niosh/docs/2010-101/pdfs/2010-101.pdf
(check this in PDF content)
29
Кузьмина Л.П., Помыканова Ю.С. Молекулярно-генетические маркеры профессиональной бронхиальной астмы с тяжелым течением. Профилактическая медицина.2016; 19 (2): 44–45.
(check this in PDF content)
30
Галущинская А.В. Риск развития нейтрофильного воспаления бронхов у детей, болеющих бронхиальной астмой, при делеционном полиморфизме генов GSTT1 и GSTM1. Современные проблемы науки и образования. 2014; 2. https://science-education.ru/ru/article/view?id= 12298
(check this in PDF content)
31
Кузьмина Л.П. Роль генетико-биохимических полиморфных систем в формировании профессиональной бронхиальной патологии от воздействия аэрозолей преимущественно фиброгенного действия. В кн.: Измеров Н.Ф., Чучалин А.Г., ред. Профессиональные заболевания органов дыхания. М.: ГЭОТАР-Медиа; 2015: 118–148.
(check this in PDF content)
32
Faisal M., Chellurl P.E., Singaraju S. et al. Environmental and occupational respiratory diseases. Spirometric abnormalities in nonsmoking bus drivers of hyderabad. World Allergy Org. J. 2013; 6 (Suppl. 1): P61. DOI: 10.1186/19394551-6-S1-P61.
(check this in PDF content)
33
Васильева О.С., Кулемина Е.А. Бронхиальная астма, вызванная ингаляцией токсико-аллергенных аэрозолей поливинилхлорида. Пульмонология. 2012; (1): 112–116.
(check this in PDF content)
34
Васильева О.С., Кузьмина Л.П., Кулемина Е.А., Коляскина М.М. Клинические и молекулярно-генетические аспекты формирования профессиональной астмы. Пульмонология. 2012; (3): 39–45.
(check this in PDF content)
35
Гланц С. Медико-биологическая статистика. М.: Практика; 1999.
(check this in PDF content)
36
Global Initiative for Asthma – GINA 2016. Available at: http:// ginasthma.org/wp-content/uploads/2016/04/wmsGINA-2016-main-report-final.pdf
(check this in PDF content)
37
Global strategy for the diagnosis, management, and prevention of chronicobstructive pulmonary disease, Global Initiative for Chronic Obstructive Lung Disease. 2016. Available at:http:// goldcopd.org/guidelines-global-strategyfor-diagnosis-management.html
(check this in PDF content)
38
Buist A.S., McBumie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007; 370 (9589): 741–750. DOI: 10.1016/S0140-6736(07)61377-4.
(check this in PDF content)
39
Eisner M.D., Blanc P.D., Omachi T.A. et al. Socioeconomic status, race and COPD health outcomes. J. Epidemiol. Community Health.2011; 65 (1): 26–34. DOI: 10.1136/jech.2009.089722.
(check this in PDF content)
40
Dodd J., Patel B. COPD genetics and epidemiology. In: Maskell N., Millar A., eds. Respiratory medicine.Oxford: Oxford University Press; 2009: 90–104. Поступила 16.02.17
(check this in PDF content)